Cargando…

Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report

In the sinonasal tract, diffuse large B-cell lymphomas are the predominant type non-Hodgkin's lymphoma while natural killer (NK) cell T-cell lymphoma, the nasal type, constitute only 3%-12% of NHLs in this region and is the more aggressive subtype. NK cell T-cell lymphoma mostly occurs in male...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandel, Devraj, Dhakal, Shishan, Thapa, Sushila, Dhakal, Prakash, Rayamajhi, Surendra, Baniya, Jagat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493876/
https://www.ncbi.nlm.nih.gov/pubmed/37701358
http://dx.doi.org/10.1016/j.radcr.2023.08.033
_version_ 1785104563280281600
author Kandel, Devraj
Dhakal, Shishan
Thapa, Sushila
Dhakal, Prakash
Rayamajhi, Surendra
Baniya, Jagat
author_facet Kandel, Devraj
Dhakal, Shishan
Thapa, Sushila
Dhakal, Prakash
Rayamajhi, Surendra
Baniya, Jagat
author_sort Kandel, Devraj
collection PubMed
description In the sinonasal tract, diffuse large B-cell lymphomas are the predominant type non-Hodgkin's lymphoma while natural killer (NK) cell T-cell lymphoma, the nasal type, constitute only 3%-12% of NHLs in this region and is the more aggressive subtype. NK cell T-cell lymphoma mostly occurs in male at the median age of 50 years and has got a poor prognosis with a 3-years overall survival (OS) of 46.3% and a 5-years OS of 42%. We present a case of a 37 year old lady with a mass in nasal cavity extending to the nasopharynx and upper cervical lymphadenopathy. Biopsy from the nasal mass showed features of NHL, NK cell T-cell type although immunohistochemistry was not available for the definite diagnosis. For localized diseases, chemo-radiotherapy forms the mainstay of treatment with complete remission in up to 50% of cases while chemotherapy alone is given to patients with disseminated disease with a very poor outcome (5-year survival of 10%-45% only). In our case, the patient received first dose of chemotherapy and then died at home before receiving the second dose showing the aggressive nature of the disease. Timely diagnosis with typical imaging features and histological diagnosis can improve the outcome with complete cure in almost half of the cases with localized disease.
format Online
Article
Text
id pubmed-10493876
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104938762023-09-12 Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report Kandel, Devraj Dhakal, Shishan Thapa, Sushila Dhakal, Prakash Rayamajhi, Surendra Baniya, Jagat Radiol Case Rep Case Report In the sinonasal tract, diffuse large B-cell lymphomas are the predominant type non-Hodgkin's lymphoma while natural killer (NK) cell T-cell lymphoma, the nasal type, constitute only 3%-12% of NHLs in this region and is the more aggressive subtype. NK cell T-cell lymphoma mostly occurs in male at the median age of 50 years and has got a poor prognosis with a 3-years overall survival (OS) of 46.3% and a 5-years OS of 42%. We present a case of a 37 year old lady with a mass in nasal cavity extending to the nasopharynx and upper cervical lymphadenopathy. Biopsy from the nasal mass showed features of NHL, NK cell T-cell type although immunohistochemistry was not available for the definite diagnosis. For localized diseases, chemo-radiotherapy forms the mainstay of treatment with complete remission in up to 50% of cases while chemotherapy alone is given to patients with disseminated disease with a very poor outcome (5-year survival of 10%-45% only). In our case, the patient received first dose of chemotherapy and then died at home before receiving the second dose showing the aggressive nature of the disease. Timely diagnosis with typical imaging features and histological diagnosis can improve the outcome with complete cure in almost half of the cases with localized disease. Elsevier 2023-09-04 /pmc/articles/PMC10493876/ /pubmed/37701358 http://dx.doi.org/10.1016/j.radcr.2023.08.033 Text en © 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kandel, Devraj
Dhakal, Shishan
Thapa, Sushila
Dhakal, Prakash
Rayamajhi, Surendra
Baniya, Jagat
Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title_full Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title_fullStr Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title_full_unstemmed Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title_short Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
title_sort natural killer cell t-cell lymphoma (nasal type), a rare and aggressive type of non-hodgkin's lymphoma: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493876/
https://www.ncbi.nlm.nih.gov/pubmed/37701358
http://dx.doi.org/10.1016/j.radcr.2023.08.033
work_keys_str_mv AT kandeldevraj naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport
AT dhakalshishan naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport
AT thapasushila naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport
AT dhakalprakash naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport
AT rayamajhisurendra naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport
AT baniyajagat naturalkillercelltcelllymphomanasaltypearareandaggressivetypeofnonhodgkinslymphomacasereport